Use of oral anticoagulants in patients with valvular atrial fibrillation: Findings from the NCDR PINNACLE Registry
Letter to the Editor
Office of the Provost; Cardiology
Recent data suggest direct oral anticoagulants are as safe and efficacious as warfarin among select patients with valvular heart disease and atrial fibrillation (AF). However, real-world treatment patterns of AF stroke prophylaxis in the setting of valvular AF are currently unknown. Accordingly, using the prospective, ambulatory National Cardiovascular Data Registry Practice Innovation and Clinical Excellence (PINNACLE) Registry, we sought to characterize overall use, temporal trends in use, and the extent of practice-level variation in the use of any direct oral anticoagulant and warfarin among patients with valvular AF from January 1, 2013, to March 31, 2019.
American Heart Journal
Hess, P. L.,
Gosch, K. L.,
Jani, S. M.,
Varosy, P. D.,
Bradley, S. M.,
Maddox, T. M.,
Virani, S. S.
(2021). Use of oral anticoagulants in patients with valvular atrial fibrillation: Findings from the NCDR PINNACLE Registry. American Heart Journal, 240, 58-62.
Available at: https://ecommons.aku.edu/provost_office/354
Issue Num are not provided by the author/publisher. This work was published before the author joined Aga Khan University